To comprehensively map the changes in EPIs with oncogenic transcriptional programmes that are relevant in MM patients, we integrated the enhancer and gene expression dynamics identified in KMS-11 and clinical samples with the p52 dependent interactome. The gene discussed is NFKB2; the disease is Miyoshi myopathy.